GGrantIndex
← Leaderboards

Soheil Meshinchi

Fred Hutchinson Cancer Research Center

$12,332,289
Attributed
$14,681,668
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,681,668 · 6

By mechanism

UG1$4,923,182 · 1
R01$4,402,328 · 1
K12$3,348,641 · 1
T32$1,350,117 · 1
R21$657,400 · 2

Top collaborators

Most similar at Fred Hutchinson Cancer Research Center

Same institution · by research overlap

Others in their field

Top investigators on “Biology

Research focus

BiologyLaboratoriesEvaluationChildhoodRelapseAdultFundingProgramsClinical ResearchClinical TrialsBaseDesignResearch Project GrantsResourcesClinical ApplicationTranslational ResearchAreaGenomicsGrantGenerationsLinkDiagnosticMolecularTherapeutic Target

Grant awards (32)

COG NCTN Integrated Translational Science Center for Hematopoietic Malignancies in Children$760,000
UG1 · FY2025 · CA · contact PI
Career Development in Pediatric and Medical Oncology$661,433
K12 · FY2025 · CA · contact PI
Pediatric Oncology Research Training Program$321,929
T32 · FY2025 · CA · contact PI
Career Development in Pediatric and Medical Oncology$677,301
K12 · FY2024 · CA · contact PI
COG NCTN Integrated Translational Science Center for Hematopoietic Malignancies in Children$427,843
UG1 · FY2024 · CA · contact PI
Pediatric Oncology Research Training Program$327,376
T32 · FY2024 · CA · contact PI
Career Development in Pediatric and Medical Oncology$567,345
K12 · FY2023 · CA · contact PI
COG NCTN Integrated Translational Science Center for Hematopoietic Malignancies in Children$535,339
UG1 · FY2023 · CA · contact PI
Pediatric Oncology Research Training Program$351,512
T32 · FY2023 · CA · contact PI
COG NCTN Integrated Translational Science Center for Hematopoietic Malignancies in Children$800,000
UG1 · FY2022 · CA · contact PI
Career Development in Pediatric and Medical Oncology$726,905
K12 · FY2022 · CA · contact PI
Pediatric Oncology Research Training Program$349,300
T32 · FY2022 · CA · contact PI
COG NCTN Integrated Translational Science Center for Hematopoietic Malignancies in Children$800,000
UG1 · FY2021 · CA · contact PI
Career Development in Pediatric and Medical Oncology$681,352
K12 · FY2021 · CA · contact PI
Career Development in Pediatric and Medical Oncology$34,305
K12 · FY2021 · CA · contact PI
COG NCTN Integrated Translational Science Center for Hematopoietic Malignancies in Children$800,000
UG1 · FY2020 · CA · contact PI
COG NCTN Integrated Translational Science Center for Hematopoietic Malignancies in Children$800,000
UG1 · FY2019 · CA · contact PI
Biology and Prognostic Implications of FLT3 Mutations in AML$429,543
R01 · FY2016 · CA · contact PI
Biology and Prognostic Implications of FLT3 Mutations in AML$429,307
R01 · FY2015 · CA · contact PI
Biology and Prognostic Implications of FLT3 Mutations in AML$416,234
R01 · FY2014 · CA · contact PI
Biology and Prognostic Implications of FLT3 Mutations in AML$412,589
R01 · FY2013 · CA · contact PI
Biology and Prognostic Implications of FLT3 Mutations in AML$463,151
R01 · FY2012 · CA · contact PI
Biology and Prognostic implications of Flt3 mutations in AML$435,609
R01 · FY2009 · CA · contact PI
Biology and Prognostic implications of Flt3 mutations in AML$171,212
R01 · FY2009 · CA · contact PI
Biology and Prognostic implications of Flt3 mutations in AML$422,916
R01 · FY2008 · CA · contact PI
Biology and Prognostic implications of Flt3 mutations in AML$421,364
R01 · FY2007 · CA · contact PI
Biology and Prognostic implications of Flt3 mutations in AML$396,224
R01 · FY2006 · CA · contact PI
Biology/prognostic implications of Flt3 mutations in AML$404,179
R01 · FY2005 · CA
Accurate Prediction of Acute Myeloid Leukemia Relapse$155,700
R21 · FY2005 · CA
Prognostic implications of Flt3 mutations in AML$173,000
R21 · FY2004 · CA
Accurate Prediction of Acute Myeloid Leukemia Relapse$155,700
R21 · FY2004 · CA
Prognostic implications of Flt3 mutations in AML$173,000
R21 · FY2003 · CA